Policies
Hypocritical U.S. Patent 6630507 on CBD Contradicts the Known Benefits of Cannabis and the Long-Known History of Medical Marijuana Use
U.S. Patent 6630507 and the Schedule-One contradiction, a tale of hypocrisy.
February 24, 2020
No Comments
